Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 454,443 | 461,097 | 387,763 | 400,745 | 353,214 |
| Cost of Goods | 95,899 | 96,949 | 77,436 | 89,182 | 75,019 |
| Gross Profit | 358,544 | 364,148 | 310,327 | 311,563 | 278,195 |
| Operating Expenses | 368,605 | 361,087 | 352,117 | 365,696 | 316,362 |
| Operating Income | -9,162 | 4,010 | -41,354 | -53,951 | -38,148 |
| Interest Expense | 6,930 | 2,937 | 6,866 | 6,727 | 7,746 |
| Other Income | 6,311 | 8,749 | 6,325 | 7,721 | 2,583 |
| Pre-tax Income | -9,781 | 9,822 | -41,895 | -52,957 | -43,311 |
| Income Tax | -24,805 | -45,214 | -4,460 | 3,516 | -39,661 |
| Net Income Continuous | 15,024 | 55,036 | -37,435 | -56,473 | -3,650 |
| Net Income | $15,024 | $55,036 | $-37,435 | $-56,473 | $-3,650 |
| EPS Basic Total Ops | 0.09 | 0.31 | -0.21 | -0.32 | -0.03 |
| EPS Basic Continuous Ops | 0.09 | 0.31 | -0.21 | -0.32 | -0.02 |
| EPS Diluted Total Ops | 0.10 | 0.30 | -0.21 | -0.32 | -0.02 |
| EPS Diluted Continuous Ops | 0.10 | 0.30 | -0.21 | -0.32 | -0.02 |
| EBITDA(a) | $16,525 | $34,362 | $-15,629 | $-32,415 | $-13,843 |